Logo image of BUI.PA

BARBARA BUI (BUI.PA) Stock Fundamental Analysis

EPA:BUI - Euronext Paris - Matif - FR0000062788 - Common Stock - Currency: EUR

3.82  0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BUI. BUI was compared to 43 industry peers in the Textiles, Apparel & Luxury Goods industry. BUI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BUI has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year BUI was profitable.
In the past year BUI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BUI reported negative net income in multiple years.
In multiple years BUI reported negative operating cash flow during the last 5 years.
BUI.PA Yearly Net Income VS EBIT VS OCF VS FCFBUI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.73%, BUI is in line with its industry, outperforming 41.86% of the companies in the same industry.
BUI has a better Return On Equity (19.87%) than 74.42% of its industry peers.
Industry RankSector Rank
ROA 2.73%
ROE 19.87%
ROIC N/A
ROA(3y)0.46%
ROA(5y)-6.8%
ROE(3y)1.78%
ROE(5y)-33.1%
ROIC(3y)N/A
ROIC(5y)N/A
BUI.PA Yearly ROA, ROE, ROICBUI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

BUI's Profit Margin of 1.99% is on the low side compared to the rest of the industry. BUI is outperformed by 76.74% of its industry peers.
BUI has a Gross Margin of 74.58%. This is amongst the best in the industry. BUI outperforms 86.05% of its industry peers.
In the last couple of years the Gross Margin of BUI has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 1.99%
GM 74.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y2.61%
BUI.PA Yearly Profit, Operating, Gross MarginsBUI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

4

2. Health

2.1 Basic Checks

BUI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BUI has about the same amount of shares outstanding.
The number of shares outstanding for BUI has been reduced compared to 5 years ago.
BUI has a better debt/assets ratio than last year.
BUI.PA Yearly Shares OutstandingBUI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K
BUI.PA Yearly Total Debt VS Total AssetsBUI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

2.2 Solvency

BUI has an Altman-Z score of 1.18. This is a bad value and indicates that BUI is not financially healthy and even has some risk of bankruptcy.
BUI has a Altman-Z score of 1.18. This is amonst the worse of the industry: BUI underperforms 81.40% of its industry peers.
The Debt to FCF ratio of BUI is 2.01, which is a good value as it means it would take BUI, 2.01 years of fcf income to pay off all of its debts.
BUI has a better Debt to FCF ratio (2.01) than 83.72% of its industry peers.
A Debt/Equity ratio of 2.09 is on the high side and indicates that BUI has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.09, BUI is doing worse than 88.37% of the companies in the same industry.
Although BUI does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 2.09
Debt/FCF 2.01
Altman-Z 1.18
ROIC/WACCN/A
WACC7.59%
BUI.PA Yearly LT Debt VS Equity VS FCFBUI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

2.3 Liquidity

BUI has a Current Ratio of 1.15. This is a normal value and indicates that BUI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BUI (1.15) is worse than 74.42% of its industry peers.
A Quick Ratio of 0.74 indicates that BUI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.74, BUI is in line with its industry, outperforming 55.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 0.74
BUI.PA Yearly Current Assets VS Current LiabilitesBUI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

2

3. Growth

3.1 Past

BUI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 126.39%, which is quite impressive.
Looking at the last year, BUI shows a small growth in Revenue. The Revenue has grown by 3.11% in the last year.
The Revenue has been growing slightly by 1.80% on average over the past years.
EPS 1Y (TTM)126.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%283.6%
Revenue 1Y (TTM)3.11%
Revenue growth 3Y10.13%
Revenue growth 5Y1.8%
Sales Q2Q%0.83%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BUI.PA Yearly Revenue VS EstimatesBUI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

BUI is valuated reasonably with a Price/Earnings ratio of 10.61.
Based on the Price/Earnings ratio, BUI is valued cheaply inside the industry as 93.02% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of BUI to the average of the S&P500 Index (26.99), we can say BUI is valued rather cheaply.
Industry RankSector Rank
PE 10.61
Fwd PE N/A
BUI.PA Price Earnings VS Forward Price EarningsBUI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

95.35% of the companies in the same industry are more expensive than BUI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.95
EV/EBITDA N/A
BUI.PA Per share dataBUI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BUI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BARBARA BUI

EPA:BUI (7/31/2025, 7:00:00 PM)

3.82

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners75.36%
Ins Owner ChangeN/A
Market Cap2.56M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.61
Fwd PE N/A
P/S 0.21
P/FCF 1.95
P/OCF 1.65
P/B 2.07
P/tB 2.37
EV/EBITDA N/A
EPS(TTM)0.36
EY9.42%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.96
FCFY51.38%
OCF(TTM)2.31
OCFY60.48%
SpS18.48
BVpS1.85
TBVpS1.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.73%
ROE 19.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.99%
GM 74.58%
FCFM 10.62%
ROA(3y)0.46%
ROA(5y)-6.8%
ROE(3y)1.78%
ROE(5y)-33.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y2.61%
F-Score7
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 2.09
Debt/FCF 2.01
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 534.55%
Current Ratio 1.15
Quick Ratio 0.74
Altman-Z 1.18
F-Score7
WACC7.59%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.69%
Cap/Sales(5y)9.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)126.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%283.6%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.11%
Revenue growth 3Y10.13%
Revenue growth 5Y1.8%
Sales Q2Q%0.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y80.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3752.78%
FCF growth 3Y1.7%
FCF growth 5YN/A
OCF growth 1Y456.84%
OCF growth 3Y-10.52%
OCF growth 5YN/A